Ex-Sarepta CEO takes helm of genetic disease startup Stoke
January 04, 2018 at 07:00 AM EST
In an interview, Ed Kaye said that he had “many opportunities” after leaving the Cambridge biotech last year, but chose Stoke partly because of his connection to one of its cofounders.